To hear about similar clinical trials, please enter your email below
Trial Title:
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
NCT ID:
NCT06484179
Condition:
Cancer
Smoking
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
Participants will be randomized to (1) Usual Care or (2) Usual Care + targeted self-help
intervention.
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Targeted Self-Help
Description:
In addition to usual care participants will receive a self-help booklet specific for
their cancer type. There are five booklets available, written at a 5-6th grade reading
level and targeted by cancer type, that explain the connection between smoking and each
cancer type, describe the benefits of quitting smoking after cancer, and address some of
the barriers cancer patients face to quit smoking when fighting cancer. Each booklet also
includes four testimonials inspired from conversations with patients.
Arm group label:
Usual Care + Targeted Self-Help Intervention
Intervention type:
Behavioral
Intervention name:
Usual Care
Description:
Participants will receive the standard care typically offered for smoking cessation.
Arm group label:
Usual Care
Summary:
The purpose of this research study is assess feasibility and acceptability of a recently
developed brief self-help intervention targeted by cancer type to increase motivation to
quit smoking.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of
breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per
cancer type). (Investigators will consider smokers individuals who report having
smoked ≥1 cigarette in the past 30 days.)
- Able to read/write English;
- Able to give informed consent;
- Not currently enrolled in a smoking cessation program;
- Age ≥18 years old.
Exclusion Criteria:
- Male patients diagnosed with breast cancer will be excluded as lifetime risk for
breast cancer in men is far below 1%
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Huntsman Cancer Institute
Address:
City:
Salt Lake City
Zip:
84112
Country:
United States
Status:
Recruiting
Contact:
Last name:
Heather Anderson
Phone:
801-585-1704
Email:
Heather.anderson@hci.utah.edu
Investigator:
Last name:
Ursula Martinez, PhD
Email:
Principal Investigator
Start date:
August 28, 2024
Completion date:
July 2027
Lead sponsor:
Agency:
University of Utah
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
University of Utah
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06484179
